Go Pro
NYSE:NVST

Envista (NVST) Stock Price, News & Analysis

Envista logo
$28.04 -0.04 (-0.12%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$28.03 -0.02 (-0.05%)
As of 08/14/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Envista Stock (NYSE:NVST)

Advanced

Key Stats

Today's Range
$27.93
$28.42
50-Day Range
$23.45
$28.74
52-Week Range
$18.77
$30.42
Volume
2.52 million shs
Average Volume
3.11 million shs
Market Capitalization
$4.50 billion
P/E Ratio
48.35
Dividend Yield
N/A
Price Target
$29.31
Consensus Rating
Moderate Buy

Company Overview

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments. Its integrated approach enables dental professionals to access consumables, equipment and digital workflow tools through a unified platform, helping to streamline procedures and enhance patient care. The company supports research and development initiatives aimed at advancing digital dentistry and improving clinical outcomes.

Envista was established in July 2019 following its spin-off from Danaher Corporation, bringing together decades of dental industry expertise under a dedicated corporate structure. Since its inception, Envista has expanded its geographic reach and invested in strategic partnerships to drive innovation and market penetration. The company’s leadership team, led by a chief executive officer and experienced executives in operations, marketing and research, focuses on long-term growth through product development, acquisitions and operational excellence.

AI Generated. May Contain Errors.

Envista Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

NVST MarketRank™: 

Envista scored higher than 38% of companies evaluated by MarketBeat, and ranked 707th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Envista has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 6 buy ratings, 9 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Envista is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Envista has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Envista's stock forecast and price target.
  • Earnings Growth

    Earnings for Envista are expected to grow by 7.19% in the coming year, from $1.53 to $1.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Envista is 48.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Envista is 48.35, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.26.

  • Price to Earnings Growth Ratio

    Envista has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Envista has a P/B Ratio of 1.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.48% of the float of Envista has been sold short.
  • Short Interest Ratio / Days to Cover

    Envista has a short interest ratio ("days to cover") of 4.64.
  • Change versus previous month

    Short interest in Envista has recently increased by 27.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Envista does not currently pay a dividend.

  • Dividend Growth

    Envista does not have a long track record of dividend growth.

  • News Sentiment

    Envista has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Envista this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for NVST on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Envista insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.99% of the stock of Envista is held by insiders.

  • Percentage Held by Institutions

    Envista has minimal institutional ownership at this time.

  • Read more about Envista's insider trading history.
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVST Stock News Headlines

Envista Holdings (NVST) Gets a Hold from Citi
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
Envista: Q2 Earnings Snapshot
Envista (NVST) Q2 2026
See More Headlines

NVST Stock Analysis - Frequently Asked Questions

Envista's stock was trading at $21.72 at the start of the year. Since then, NVST shares have increased by 29.1% and is now trading at $28.0450.

Envista Holdings Corporation (NYSE:NVST) posted its quarterly earnings results on Wednesday, August, 5th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.07. The business's revenue for the quarter was up 7.1% compared to the same quarter last year.
Read the conference call transcript
.

Envista (NVST) raised $602 million in an IPO on Wednesday, September 18th 2019. The company issued 26,768,000 shares at a price of $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Envista's top institutional investors include Bank of New York Mellon Corp (0.87%), Pzena Investment Management LLC (0.71%), Algert Global LLC (0.41%) and Parkman Healthcare Partners LLC (0.34%). Insiders that own company stock include Amir Aghdaei, Eric Conley, Mark E Nance, Mischa Reis, Eric D Hammes and Stephen Keller.
View institutional ownership trends
.

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Envista investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), The RMR Group (RMR) and AUO (AUOTY).

Company Calendar

Last Earnings
8/05/2026
Today
8/15/2026
Investor Day 2026
9/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NYSE:NVST
CIK
1757073
Employees
12,000
Year Founded
2018

Price Target and Rating

High Price Target
$35.00
Low Price Target
$23.00
Potential Upside/Downside
+4.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
16 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.58
Trailing P/E Ratio
48.35
Forward P/E Ratio
18.33
P/E Growth
1.34
Net Income
$47 million
Net Margins
3.33%
Pretax Margin
8.20%
Return on Equity
7.88%
Return on Assets
4.33%

Debt

Debt-to-Equity Ratio
0.47
Current Ratio
2.43
Quick Ratio
2.07

Sales & Book Value

Annual Sales
$2.72 billion
Price / Sales
1.66
Cash Flow
$2.17 per share
Price / Cash Flow
12.93
Book Value
$19.15 per share
Price / Book
1.46

Miscellaneous

Outstanding Shares
160,620,000
Free Float
159,028,000
Market Cap
$4.50 billion
Optionable
Optionable
Beta
0.86

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NYSE:NVST) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners